# Beijing Yingtong Technology Development Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-yingtong-technology-development-co

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.airdoc.com
- Latest round: Series D (Jun 18, 2021)
- Investors on record: 16

## About

Established in 2015 and based in Beijing, China, Beijing Yingtong Technology Development Co., Ltd. trading business as Airdoc is an AI medical image recognition technology developer focused on the application of AI medical image recognition.

Airdoc's artificial intelligence chronic disease recognition system can automatically read the retinal images taken by the fundus camera, and form the medical image recognition algorithm model service under the guidance of medical experts. Using the chronic disease recognition algorithm, rapid analysis and screening can be completed to help doctors improve efficiency.

## Funding rounds

- Series D, Jun 18, 2021 — OrbiMed Advisors, Lilly Asia Ventures, Lake Bleu Capital
- Series C, Dec 3, 2020 — Fuho Capital, Sunhope Capital, Sunshine Guojian Pharmaceutical (Shanghai) Co.,Ltd., Beijing Zhongxiang Yunda Investment
- Series C, Oct 30, 2020 — CITIC Capital Holdings, Haiyin Capital, Xishan Angel Foundation, Avic Trust, Kaiyan Investment, Shandong Institute of Industrial Technology
- Series B, Apr 2, 2018 — Fosun International, Beijing Sogou Information Service Co., Ltd.
- Angel, Dec 21, 2015 — Unity Ventures

## Investors

- Unity Ventures (https://capitalatlas.ai/funds/unity-ventures) — Angel
- Fosun International (https://capitalatlas.ai/funds/fosun-international) — Series B
- Beijing Sogou Information Service Co., Ltd. — Series B
- CITIC Capital Holdings (https://capitalatlas.ai/funds/citic-capital-holdings) — Series C
- Haiyin Capital (https://capitalatlas.ai/funds/haiyin-capital) — Series C
- Xishan Angel Foundation — Series C
- Avic Trust (https://capitalatlas.ai/funds/avic-trust) — Series C
- Kaiyan Investment — Series C
- Shandong Institute of Industrial Technology — Series C
- Fuho Capital (https://capitalatlas.ai/funds/fuho-capital) — Series C
- Sunhope Capital (https://capitalatlas.ai/funds/sunhope-capital) — Series C
- Sunshine Guojian Pharmaceutical (Shanghai) Co.,Ltd. — Series C
- Beijing Zhongxiang Yunda Investment (https://capitalatlas.ai/funds/beijing-zhongxiang-yunda-investment) — Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series D
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series D
- Lake Bleu Capital (https://capitalatlas.ai/funds/lake-bleu-capital) — Series D